Viewing Study NCT00470704


Ignite Creation Date: 2025-12-24 @ 9:11 PM
Ignite Modification Date: 2026-01-25 @ 4:05 AM
Study NCT ID: NCT00470704
Status: COMPLETED
Last Update Posted: 2024-12-19
First Post: 2007-05-07
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer
Sponsor: Nancy Lin, MD
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HER2-positive breast cancer View
None Herceptin View
None trastuzumab View